SK Chemical’s Lou Gehrig's disease treatment ‘Teglutik’ can now be prescribed at general hospitals in Korea.

According to industry sources, Teglutik (riluzole) passed the drug committees (DCs) of tertiary hospitals including Samsung Medical Center, Seoul National University Hospital, Asan Medical Center, as well as medical institutions such as Pusan National University Hospital

The drug, which was released this year, was approved by the Ministry of Food and Drug Safety in May last year to extend the survival period or delay tracheostomy in patients with amyotrophic lateral sclerosis (ALS)

ALS, which is also commonly referred to as Lou Gehrig's disease, is a neurodege